203 related articles for article (PubMed ID: 27599791)
1. SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cells.
Choi EK; Kim SM; Hong SW; Moon JH; Shin JS; Kim JH; Hwang IY; Jung SA; Lee DH; Lee EY; Lee S; Kim H; Kim D; Kim YS; Choi YK; Kim HI; Choi HS; Cho SG; Kim JE; Kim KP; Hong YS; Lee WK; Lee JS; Kim TW; Ko SG; Jin DH
Mol Med Rep; 2016 Oct; 14(4):3955-60. PubMed ID: 27599791
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Effect of SH003 and Doxorubicin in Triple-negative Breast Cancer.
Woo SM; Kim AJ; Choi YK; Shin YC; Cho SG; Ko SG
Phytother Res; 2016 Nov; 30(11):1817-1823. PubMed ID: 27476488
[TBL] [Abstract][Full Text] [Related]
3. Anti-Proliferative and Pro-Apoptotic Effects of
Alehaideb Z; AlGhamdi S; Yahya WB; Al-Eidi H; Alharbi M; Alaujan M; Albaz A; Tukruni M; Nehdi A; Abdulla MH; Matou-Nasri S
J Evid Based Integr Med; 2020; 25():2515690X20978391. PubMed ID: 33302699
[TBL] [Abstract][Full Text] [Related]
4. SH003 reverses drug resistance by blocking signal transducer and activator of transcription 3 (STAT3) signaling in breast cancer cells.
Seo HS; Ku JM; Lee HJ; Woo JK; Cheon C; Kim M; Jang BH; Shin YC; Ko SG
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28864784
[TBL] [Abstract][Full Text] [Related]
5. Chloroform Fraction of Methanolic Extract of Seeds of Annona muricata Induce S Phase Arrest and ROS Dependent Caspase Activated Mitochondria-Mediated Apoptosis in Triple-Negative Breast Cancer.
Kariyil BJ; Ayyappan UPT; Gopalakrishnan A; George AJ
Anticancer Agents Med Chem; 2021; 21(10):1250-1265. PubMed ID: 32951586
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of Xi Huang pills on MDA‑MB‑231 cells in vitro and in vivo.
Zheng W; Han S; Jiang S; He X; Li X; Ding H; Cao M; Li P
Mol Med Rep; 2018 Aug; 18(2):2068-2078. PubMed ID: 29956784
[TBL] [Abstract][Full Text] [Related]
7. SH003‑induced G1 phase cell cycle arrest induces apoptosis in HeLa cervical cancer cells.
Lee KM; Lee K; Choi YK; Choi YJ; Seo HS; Ko SG
Mol Med Rep; 2017 Dec; 16(6):8237-8244. PubMed ID: 28944910
[TBL] [Abstract][Full Text] [Related]
8. Gambogic acid increases the sensitivity to paclitaxel in drug‑resistant triple‑negative breast cancer via the SHH signaling pathway.
Wang Y; Sui Y; Tao Y
Mol Med Rep; 2019 Nov; 20(5):4515-4522. PubMed ID: 31545492
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of FOXO1‑mediated autophagy promotes paclitaxel‑induced apoptosis of MDA‑MB‑231 cells.
Xu K; Zhu W; Xu A; Xiong Z; Zou D; Zhao H; Jiao D; Qing Y; Jamal MA; Wei HJ; Zhao HY
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 35014689
[TBL] [Abstract][Full Text] [Related]
11. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.
Zhu A; Li Y; Song W; Xu Y; Yang F; Zhang W; Yin Y; Guan X
Cell Physiol Biochem; 2016; 38(3):1003-14. PubMed ID: 26938985
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.
You KS; Yi YW; Kwak SJ; Seong YS
Int J Oncol; 2018 Mar; 52(3):828-840. PubMed ID: 29344641
[TBL] [Abstract][Full Text] [Related]
14. SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer.
Choi YJ; Lee K; Yoon JH; Cho SG; Kim YG; Jeong M; Hwang HH; Lee SY; Jung SE; Ko SG
Biomed Res Int; 2022; 2022():3647900. PubMed ID: 35572726
[TBL] [Abstract][Full Text] [Related]
15. SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway.
Choi YJ; Choi YK; Lee KM; Cho SG; Kang SY; Ko SG
BMC Complement Altern Med; 2016 Dec; 16(1):507. PubMed ID: 27927199
[TBL] [Abstract][Full Text] [Related]
16. PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim.
Byerly JH; Port ER; Irie HY
Breast Cancer Res; 2020 Jun; 22(1):72. PubMed ID: 32600444
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53.
Sutton KM; Greenshields AL; Hoskin DW
Nutr Cancer; 2014; 66(3):408-18. PubMed ID: 24579801
[TBL] [Abstract][Full Text] [Related]
18. SH003 enhances paclitaxel chemosensitivity in MCF-7/PAX breast cancer cells through inhibition of MDR1 activity.
Choi HS; Cho SG; Kim MK; Lee HJ; Moon SH; Jang HJ; Ko SG
Mol Cell Biochem; 2017 Feb; 426(1-2):1-8. PubMed ID: 27854072
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3.
Abd El-Hafeez AA; Khalifa HO; Mahdy EAM; Sharma V; Hosoi T; Ghosh P; Ozawa K; Montano MM; Fujimura T; Ibrahim ARN; Abdelhamid MAA; Pack SP; Shouman SA; Kawamoto S
Pharmacol Rep; 2019 Apr; 71(2):289-298. PubMed ID: 30826569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
